| Product NDC: | 64543-350 |
| Proprietary Name: | Liquibid D-R |
| Non Proprietary Name: | Guaifenesin and Phenylephrine |
| Active Ingredient(s): | 400; 10 mg/1; mg/1 & nbsp; Guaifenesin and Phenylephrine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, MULTILAYER |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 64543-350 |
| Labeler Name: | Capellon Pharmaceuticals, LLC |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20080618 |
| Package NDC: | 64543-350-90 |
| Package Description: | 90 TABLET, MULTILAYER in 1 BOTTLE (64543-350-90) |
| NDC Code | 64543-350-90 |
| Proprietary Name | Liquibid D-R |
| Package Description | 90 TABLET, MULTILAYER in 1 BOTTLE (64543-350-90) |
| Product NDC | 64543-350 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Guaifenesin and Phenylephrine |
| Dosage Form Name | TABLET, MULTILAYER |
| Route Name | ORAL |
| Start Marketing Date | 20080618 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Capellon Pharmaceuticals, LLC |
| Substance Name | GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE |
| Strength Number | 400; 10 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes |